WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 5 fonti

New drug could be game changer for people with high cholesterol

Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer for treating high cholesterol.

Raccontata dabiopharmadive.combenzinga.comarstechnica.comtime.comabcnews.com

Confronto fonti

5 prospettive sulla stessa storia
AI · summaries
abcnews.comStai leggendo5 h fa

New drug could be game changer for people with high cholesterol

Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer for treating high cholesterol.

originale
biopharmadive.com2 g fa

Early data for heart drug affirm Lilly’s billion-dollar bet on Verve

The base editing medicine lowered “bad” cholesterol levels along with a key protein, clearing the way for a Phase 2 study.

Leggi questa versione → originale
arstechnica.com7 h fa

Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

The interim Phase I trial data was only from 35 people, but results look good so far.

Leggi questa versione → originale
time.com7 h fa

A One-Time Experimental Treatment Might Control Cholesterol for Life

If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular injections.

Leggi questa versione → originale
benzinga.com2 g fa

Chamath Palihapitiya Said This To Eli Lilly's Gene Therapy That Slashes LDL Cholesterol Up To 62% - Eli L

Chamath Palihapitiya reacted on X after Eli Lilly's VERVE-102 showed strong Phase 1b LDL cholesterol reduction results.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 26 maggio 2026·biopharmadive.com

    Early data for heart drug affirm Lilly’s billion-dollar bet on Verve

    The base editing medicine lowered “bad” cholesterol levels along with a key protein, clearing the way for a Phase 2 study.

  2. martedì 26 maggio 2026·benzinga.com

    Chamath Palihapitiya Said This To Eli Lilly's Gene Therapy That Slashes LDL Cholesterol Up To 62% - Eli L

    Chamath Palihapitiya reacted on X after Eli Lilly's VERVE-102 showed strong Phase 1b LDL cholesterol reduction results.

  3. giovedì 28 maggio 2026·arstechnica.com

    Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

    The interim Phase I trial data was only from 35 people, but results look good so far.

  4. giovedì 28 maggio 2026·arstechnica.com

    One dose of gene-editing drug cut bad cholesterol 62% for months in small trial

    The interim Phase I trial data was only from 35 people, but results look good so far.

  5. giovedì 28 maggio 2026·time.com

    A One-Time Experimental Treatment Might Control Cholesterol for Life

    If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular injections.

  6. giovedì 28 maggio 2026·abcnews.com

    New drug could be game changer for people with high cholesterol

    Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer for treating high cholesterol.